EDIT vs PEP · rev $32.3M vs P/E 22, rev $93.92B
Editas Medicine Inc (EDIT) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PEP revenue for 2025-12-27 was $93.92B. Net income was $8.24B. Revenue was up 2.3% from 2024-12-28 to 2025-12-27. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
EDIT currently screens at market cap $375.2M. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the EDIT and PEP stock pages for the full models.
Not investment advice.